FREQUENCY AND CHARACTERISTICS OF INTRAOCULAR INFLAMMATION AFTER AFLIBERCEPT INJECTION

被引:20
|
作者
Fine, Howard F. [1 ]
Roth, Daniel B. [1 ]
Shah, Sumit P. [1 ]
Haque, Tahia [1 ]
Wheatley, Matthew [1 ]
机构
[1] Rutgers Robert Wood Johnson Med Sch, Dept Ophthalmol, New Brunswick, NJ 08901 USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2015年 / 35卷 / 04期
关键词
aflibercept; endophthalmitis; intravitreal injection; noninfectious endophthalmitis; uveitis; INTRAVITREAL INJECTION; MACULAR DEGENERATION; RANIBIZUMAB INJECTIONS; BEVACIZUMAB; SAFETY; VERTEPORFIN;
D O I
10.1097/IAE.0000000000000398
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report the frequency and characteristics of intraocular inflammation after intravitreal aflibercept injection. Methods: A single-center retrospective study was performed in patients who received intravitreal aflibercept from November 2011 through June 2013. Results: There were 28 cases of intraocular inflammation after a total of 5,905 aflibercept injections among 1,660 patients. The mean baseline acuity was 20/57, which decreased to 20/179 at diagnosis (P < 0.0001) but recovered to 20/59 at Month 1, 20/57 at Month 3, and 20/52 at Month 6 (P = not significant). Vitreous culture and injection of antibiotics were performed in eight cases, and all were culture negative; the remainder received only topical corticosteroids. Conclusion: The frequency of inflammation after aflibercept was 0.47% per injection. Visual acuity and inflammation returned to baseline within 1 month in most cases with topical corticosteroid treatment.
引用
收藏
页码:681 / 686
页数:6
相关论文
共 50 条
  • [11] Incidence of severe rise in intraocular pressure after intravitreous injection of aflibercept with prefilled syringes
    Dingerkus, Vita Louisa Sophie
    Somfai, Gabor Mark
    Kinzl, Stephan
    Orgul, Selim Ismet
    Becker, Matthias Dieter
    Heussen, Florian Moritz
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [12] Incidence of severe rise in intraocular pressure after intravitreous injection of aflibercept with prefilled syringes
    Vita Louisa Sophie Dingerkus
    Gabor Mark Somfai
    Stephan Kinzl
    Selim Ismet Orgül
    Matthias Dieter Becker
    Florian Moritz Heussen
    Scientific Reports, 12
  • [13] Aflibercept-Related Sterile Intraocular Inflammation Outcomes
    Greenberg, Jonathan P.
    Belin, Peter
    Butler, John
    Feiler, Daniel
    Mueller, Christian
    Tye, Andrew
    Friedlander, Steven M.
    Emerson, Geoffrey G.
    Ferrone, Philip J.
    OPHTHALMOLOGY RETINA, 2019, 3 (09): : 753 - 759
  • [14] Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
    Baumal, Caroline R.
    Spaide, Richard F.
    Vajzovic, Lejla
    Freund, K. Bailey
    Walter, Scott D.
    John, Vishak
    Rich, Ryan
    Chaudhry, Nauman
    Lakhanpal, Rohit R.
    Oellers, Patrick R.
    Leveque, Thellea K.
    Rutledge, Bryan K.
    Chittum, Mark
    Bacci, Tommaso
    Enriquez, Ana Bety
    Sund, Newman J.
    Subong, Eric N. P.
    Albini, Thomas A.
    OPHTHALMOLOGY, 2020, 127 (10) : 1345 - 1359
  • [15] A Prospective Masked Clinical Assessment of Inflammation After Intravitreal Injection of Ranibizumab or Aflibercept
    Khanani, Arshad M.
    Cohen, Gregory L.
    Zawadzki, Rezi
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (04) : 216 - 218
  • [16] Increased Risk of Severe Rise in Intraocular Pressure after Intravitreous Injection of Aflibercept with Prefilled Syringes
    Dingerkus, Vita Louisa Sophie
    Somfai, Gabor Mark
    Heussen, Florian Moritz
    Kinzl, Stephan
    Becker, Matthias Dieter
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [17] Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
    Georgopoulos, M.
    Polak, K.
    Prager, F.
    Pruente, C.
    Schmidt-Erfurth, U.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (04) : 457 - 462
  • [18] Postmarketing Analysis of Aflibercept-Related Sterile Intraocular Inflammation
    Hahn, Paul
    Chung, Mina M.
    Flynn, Harry W., Jr.
    Huang, Suber S.
    Kim, Judy E.
    Mahmoud, Tamer H.
    Sadda, SriniVas R.
    Dugel, Pravin U.
    JAMA OPHTHALMOLOGY, 2015, 133 (04) : 421 - 426
  • [19] Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
    Hashiya, Nozomu
    Maruko, Ichiro
    Miyaguchi, Yuri
    Maruko, Ruka
    Hasegawa, Taiji
    Iida, Tomohiro
    BMC OPHTHALMOLOGY, 2025, 25 (01)
  • [20] Short-term effect on intraocular pressure after intravitreal aflibercept injection for diabetic macular edema
    Alshehri, Tariq S.
    Alshehri, Afnan A.
    Hassan, Ahmed
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)